Agilent SureSelect cancer custom panels

Agilent SureSelect Cancer Custom panels enable tumor genomic profiling with next-generation sequencing (NGS) panels customized to fit specific laboratory requirements, including the incorporation of new and emerging biomarkers. SureSelect Cancer Custom panels are combined with library preparation and target enrichment reagents to enable detection of all key classes of somatic changes, including single nucleotide variants (SNVs), copy number variants (CNVs), insertions/ deletions (indels), and translocations (TLs). Agilent Technologies highlights data demonstrating the high target coverage achieved by SureSelect Cancer Custom panels for assays; and their consistent detection of key somatic variant classes.